News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,616 Results
Type
Article (27093)
Company Profile (43)
Press Release (385474)
Multimedia
Podcasts (50)
Webinars (7)
Section
Business (119766)
Career Advice (459)
Deals (17159)
Drug Delivery (76)
Drug Development (48217)
Employer Resources (48)
FDA (12546)
Job Trends (8710)
News (189181)
Policy (20173)
Tag
2025 Best Places to Work (8)
2026 Best Places to Work (12)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (1822)
Accelerated approval (42)
ADA (32)
Adcomms (12)
Allergies (168)
Alliances (27132)
ALS (164)
Alzheimer's disease (1162)
Antibody-drug conjugate (ADC) (420)
Approvals (13310)
Artificial intelligence (514)
ASCO (211)
Autoimmune disease (286)
Automation (18)
Bankruptcy (154)
Belgium (22)
Best Places to Work (7048)
BIO (29)
Biologics (60)
Biomarkers (1)
BIOSECURE Act (5)
Biosimilars (136)
BioSpace Insights (78)
Biotechnology (27)
Bispecific (50)
Bladder cancer (197)
Brain cancer (58)
Breast cancer (614)
Cancer (4949)
Cardiovascular disease (407)
Career advice (431)
Career pathing (19)
CAR-T (194)
CDC (39)
CDMO (64)
Celiac Disease (8)
Cell-line development (1)
Cell therapy (545)
Cervical cancer (49)
Clinical research (45854)
Collaboration (1350)
Commercialization (56)
Company closure (2)
Compensation (389)
Complete response letters (39)
COVID-19 (1627)
CRISPR (59)
CRO (6)
C-suite (939)
Cystic fibrosis (75)
Data (7469)
Decentralized trials (3)
Denatured (27)
Depression (144)
Dermatology (151)
Diabetes (513)
Diagnostics (4170)
Digital health (55)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (163)
Drug pricing (160)
Drug shortages (24)
Duchenne muscular dystrophy (177)
Earnings (41561)
Editorial (42)
Employer branding (6)
Employer resources (49)
ESMO (414)
Events (58178)
Executive appointments (788)
Eye disease (15)
FDA (16273)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (4)
Friedreich's ataxia (12)
Frontotemporal dementia (20)
Funding (1144)
Gene editing (117)
Generative AI (37)
Gene therapy (415)
GLP-1 (704)
Government (3346)
Grass and pollen (4)
Guidances (283)
Healthcare (12696)
Hematology (147)
HIV (80)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (13)
IgA nephropathy (91)
Immunology and inflammation (112)
Immuno-oncology (82)
Indications (215)
Infectious disease (1850)
Inflammatory bowel disease (166)
Inflation Reduction Act (12)
Influenza (77)
Intellectual property (185)
Interviews (42)
IPO (7193)
IRA (40)
Job creations (1875)
Job search strategy (389)
JPM (19)
Kidney cancer (20)
Kidney disease (124)
Labor market (63)
Layoffs (229)
Leadership (13)
Legal (3917)
Licensing (66)
Liver cancer (82)
Longevity (22)
Lung cancer (787)
Lung diease (16)
Lymphoma (396)
Machine learning (32)
Management (19)
Manufacturing (558)
Marketing (24)
MASH (161)
Medical affairs (6)
Medical device (13756)
Medtech (14072)
Melanoma (81)
Mergers & acquisitions (10749)
Metabolic disorders (1194)
Middle East (2)
mRNA (125)
Multiple sclerosis (166)
NASH (12)
Netherlands (23)
Neurodegenerative disease (285)
Neuropsychiatric disorders (71)
Neuroscience (2386)
Neurotech (1)
NextGen: Class of 2026 (4023)
Non-profit (2986)
Now hiring (54)
Obesity (483)
Opinion (131)
Ovarian cancer (208)
Pain (243)
Pancreatic cancer (278)
Parkinson's disease (262)
Partnered (22)
Patents (369)
Patient advocacy (7)
Patient recruitment (695)
Patient selection (81)
Peanut (55)
People (37249)
Peptides (24)
Pharmaceutical (14)
Pharmacy benefit managers (25)
Phase 1 (13109)
Phase 2 (19849)
Phase 3 (16364)
Pipeline (9178)
Policy (191)
Postmarket research (1682)
Preclinical (4026)
Press Release (18)
Prostate cancer (289)
Psychedelics (41)
Radioligand (2)
Radiopharmaceuticals (270)
Rare diseases (790)
Real estate (2906)
Recruiting (20)
Regenerative medicine (25)
Regulatory (17852)
Reports (31)
Research institute (1735)
Resumes & cover letters (51)
Rett syndrome (34)
RNA editing (13)
RSV (55)
Saudi Arabia (1)
Schizophrenia (168)
Series A (190)
Series B (132)
Series C (1)
Service/supplier (2)
Sickle cell disease (82)
Special edition (11)
Spinal muscular atrophy (113)
Sponsored (19)
Startups (2163)
Stem cells (4)
Stomach cancer (13)
Substance use disorders (16)
Supply chain (87)
Switzerland (16)
Tariffs (41)
Tax incentives (2)
The Weekly (23)
Vaccines (658)
Venture capital (47)
Weight loss (318)
Wet AMD (4)
Women's health (117)
Worklife (5)
Date
Last 7 days (366)
Last 30 days (1913)
Last 365 days (16979)
2026 (15668)
2025 (16645)
2024 (20016)
2023 (22926)
2022 (30874)
2021 (33214)
2020 (32527)
2019 (28889)
2018 (22234)
2017 (19092)
2016 (18351)
2015 (21402)
2014 (16188)
2013 (13404)
2012 (14517)
2011 (14833)
2010 (13378)
Location
Africa (386)
Alabama (36)
Alaska (2)
Arizona (307)
Arkansas (12)
Asia (26805)
Australia (4240)
California (8416)
Canada (2650)
China (1392)
Colorado (463)
Connecticut (440)
Delaware (367)
Europe (52786)
Florida (1405)
Georgia (349)
Hawaii (2)
Idaho (35)
Illinois (955)
India (57)
Indiana (548)
Iowa (16)
Japan (583)
Kansas (110)
Kentucky (37)
Louisiana (48)
Maine (32)
Maryland (1183)
Massachusetts (5574)
Michigan (217)
Minnesota (665)
Mississippi (7)
Missouri (114)
Montana (21)
Nebraska (23)
Nevada (112)
New Hampshire (80)
New Jersey (2922)
New Mexico (11)
New York (2460)
North Carolina (1140)
North Dakota (5)
Northern California (4185)
Ohio (304)
Oklahoma (12)
Oregon (31)
Pennsylvania (1912)
Puerto Rico (19)
Rhode Island (47)
South America (554)
South Carolina (90)
Southern California (3531)
Tennessee (210)
Texas (1656)
United States (32308)
Utah (288)
Virginia (224)
Washington D.C. (53)
Washington State (608)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
412,616 Results for "kahr medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Regulation Of New Medical Tech Is Becoming A Lifelong Process
The Regulation Of New Medical Tech Is Becoming A Lifelong Process
October 26, 2026
·
1 min read
Pharm Country
Myeloma Investment Fund Invests in KAHR to Explore Potential of KAHR’s Lead Immunotherapy Drug Candidate for the Treatment of Multiple Myeloma
KAHR and the Myeloma Investment Fund announced that the MIF has invested in KAHR to explore the potential of DSP107, KAHR’s lead immunotherapy drug candidate, for the treatment of multiple myeloma.
November 17, 2022
·
4 min read
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Sponsored
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
As AI-enabled Software as Medical Devices become more prevalent, regulatory agencies are responding with new guidelines and AI-specific authorisation routes. This article looks at current trends, suggests clinical considerations for medical device developers and anticipates AI-enabled SaMDs’ future progress.
August 17, 2026
·
6 min read
·
JoAnne Bronikowski
Press Releases
Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
November 3, 2026
·
4 min read
Drug Development
KAHR Reports Dose Escalation Results from Phase I Trial of DSP107 in Combination with anti-PD-L1 in Patients with Advanced Solid Tumors
KAHR today announced positive results from the dose escalation Phase I study of DSP107 in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors.
May 31, 2023
·
4 min read
Business
KAHR Announces Appointment of Jennifer Minai-Azary to its Board of Directors
KAHR , a clinical-stage cancer immunotherapy company developing novel bi-functional fusion proteins, today announced the appointment of Jennifer Minai-Azary to its Board of Directors. The appointment is effective immediately.
July 11, 2022
·
2 min read
Press Releases
AVITA Medical Reports Third Quarter Results
November 6, 2026
·
12 min read
Press Releases
Vivani Medical Announces Private Placement Equity Financing
November 16, 2026
·
5 min read
Press Releases
New CEO and executive medical director named for Washington Permanente Medical Group
September 30, 2026
·
4 min read
1 of 41,262
Next